Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE)

Clin Adv Hematol Oncol. 2010 Nov;8(11):806-9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Benzoates / therapeutic use*
  • Blood Platelets / drug effects
  • Bone Marrow Diseases / etiology
  • Bone Marrow Diseases / therapy
  • Female
  • Humans
  • Hydrazines / therapeutic use*
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Megakaryocytes / drug effects
  • Megakaryocytes / pathology
  • Middle Aged
  • Molecular Mimicry
  • Purpura, Thrombocytopenic / etiology
  • Purpura, Thrombocytopenic / therapy
  • Pyrazoles / therapeutic use*
  • Receptors, Thrombopoietin / agonists
  • Remission Induction
  • Treatment Outcome

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • eltrombopag

Supplementary concepts

  • Acquired amegakaryocytic thrombocytopenia